quinazolines has been researched along with Thrombocythemia in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.23) | 18.7374 |
| 1990's | 12 (19.35) | 18.2507 |
| 2000's | 41 (66.13) | 29.6817 |
| 2010's | 5 (8.06) | 24.3611 |
| 2020's | 2 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Fleischman, A; Gotlib, J; Heaney, M; Hoffman, R; Kremyanskaya, M; Kuykendall, A; Mascarenhas, J; Mesa, R; O'Connell, C; Podoltsev, N; Rippel, N; Shammo, JM; Tremblay, D; Yacoub, A; Zubizarreta, N | 1 |
| Cario, H; Duffert, CM; Knöfler, R; Kulozik, AE; Stockklausner, C; Streif, W | 1 |
| Hwang, JH; Kim, DW; Kim, KS; Lee, SY | 1 |
| Aiba, K; Fujiwara, Y; Furukawa, K; Futagawa, Y; Kitamura, H; Misawa, T; Shiba, H; Tsutsui, N; Uwagawa, T; Yanaga, K | 1 |
| Chaudhary, R; Nityanand, S; Singh, A | 1 |
| Brychtová, Y; Campr, V; Černá, O; Červinek, L; Cmunt, E; Doubek, M; Dulíček, P; Kissová, J; Křen, L; Maaloufová Soukupová, J; Ovesná, P; Penka, M; Schwarz, J | 1 |
| Birgegård, G | 1 |
| D'adda, M; Drera, M; Ferrari, S; Micheletti, M; Rossi, G | 1 |
| Emadi, A; Spivak, JL | 1 |
| Gisslinger, H; Krumpl, G; Linkesch, W; Petrides, PE; Schüller, A; Steurer, M; Widmann, R | 1 |
| Bodzásová, C; Brychtová, Y; Cerná, O; Doubek, M; Dulícek, P; Dusek, L; Hadacová, I; Hlusí, A; Hochová, I; Indrák, K; Jelínková, P; Jonásová, A; Kissová, J; Korístek, Z; Nováková, L; Pavlík, T; Penka, M; Pospísilová, D; Schutzová, M; Schwarz, J; Segethová, J; Voglová, J; Vozobulová, V; Walterová, L | 1 |
| Chen, YG; Chian, CF; Lin, CS; Shen, CH | 1 |
| Lev, PR; Marta, RF; Molinas, FC; Vassallu, P | 1 |
| Kvasnicka, HM; Schmitt-Gräff, A; Thiele, J | 1 |
| Erusalimsky, JD; Hong, Y | 1 |
| Brink, DJ; Mazer, MA; Raghavan, M | 1 |
| Brunnbauer, K; Fuchs, N; Kvasnicka, HM; Schmitt-Graeff, A; Thiele, J; Volkwein, N | 1 |
| Schafer, AI | 1 |
| Birgegård, G; Björkholm, M; Kutti, J; Lärfars, G; Löfvenberg, E; Markevärn, B; Mauritzson, N; Merup, M; Palmblad, J; Samuelsson, J; Westin, J | 2 |
| Cheung, MC; Hicks, LK; Pendergrast, J | 1 |
| Dingli, D; Tefferi, A | 2 |
| Gastl, G; Gisslinger, H; Jedrzejczak, WW; Lin, W; Pytlik, R; Schlögl, E; Steurer, M | 1 |
| Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Mourits-Andersen, T; Nielsen, OJ; Penninga, E | 1 |
| Silver, RT | 1 |
| Dame, C; Sutor, AH | 1 |
| Alkindi, S; Dennison, D; Pathare, A | 1 |
| Fruchtman, S | 1 |
| Harrison, CN | 1 |
| Najda, J; Stella-Hołowiecka, B | 1 |
| Jantunen, E; Kuittinen, T; Nousiainen, T; Penttilä, K | 1 |
| Belada, D; Brychtová, Y; Bubeník, B; Cerná, O; Doubek, M; Dulícek, P; Dusek, L; Hadacová, I; Hlusí, A; Hochová, I; Kissová, J; Lhot'anová, T; Micaníková, M; Penka, M; Pytlík, R; Schutzová, M; Schwarz, J; Seghetová, J; Siroký, O; Szotkowski, T; Voglová, J; Volková, Z; Vozobulová, V; Vránová, M | 1 |
| Beránek, M; Chrobák, L; Maisnar, V; Voglová, J | 1 |
| Goette, NP; Marta, RF; Molinas, FC | 1 |
| Bernhardt, B; Peerschke, EI; Silver, RT; Varon, D; Weksler, BB; Yin, W | 1 |
| Dissemond, J; Grabbe, S; Körber, A; Rappoport, L | 1 |
| Birgegård, G; Engström-Laurent, A; Hultdin, M; Lundström, B; Samuelsson, J; Sundström, G; Wahlin, A | 1 |
| Brychtová, Y; Bubeník, B; Cerná, O; Doubek, M; Dulícek, P; Dusek, L; Hadacová, I; Hlusí, A; Hochová, I; Kissová, J; Lhotanová, T; Micaníková, M; Pavlík, T; Penka, M; Pospísilová, D; Pytlík, R; Schützová, M; Schwarz, J; Seghetová, J; Szotkowski, T; Voglová, J; Volková, Z; Vozobulová, V; Vránová, M; Zapletal, O | 1 |
| Bareford, D; Buck, G; Campbell, PJ; East, CL; Erber, WN; Green, AR; Harrison, CN; Paul, B; Wheatley, K; Wilkins, BS | 1 |
| Brogden, RN; Spencer, CM | 1 |
| Mughal, TI | 1 |
| Petitt, RM; Petrone, ME; Silverstein, MN | 1 |
| Elliott, MA; Silverstein, MN; Solberg, LA; Tefferi, A | 1 |
| Lindemann, A; Mertelsmann, R; Schoepf, E; Wirth, K | 1 |
| Fuchs, D; Hempel, L; Hermann, J; Sauerbrey, A; Zintl, F | 1 |
| Adam, H; Burkhard, R; Honegger, HP; Widmer, L | 1 |
| Brooks, WG; Goode, JV; Stanley, DD | 1 |
| Kornblihtt, LI; Laguna, MS; Marta, RF; Michiels, JJ; Molinas, FC | 1 |
| Bennett, M | 1 |
| Balon, J; Bieniaszewska, M; Hellmann, A | 1 |
| Pavithran, K; Somarajan, A; Thomas, M | 1 |
| Gilbert, HS | 2 |
| Eftyhiadis, E; Komninaka, V; Loukopoulos, D; Mantzourani, M; Terpos, E; Voskaridou, E | 1 |
| Solberg, LA | 1 |
| Adams, J; Bennett, CL; Dave, S; Golub, R | 1 |
| Frenkel, EP | 1 |
| Fleming, JS; Knight, RC; Petitt, RM; Schacter, LP; Silverstein, MN; Solberg, LA | 1 |
| Adamson, JW | 1 |
20 review(s) available for quinazolines and Thrombocythemia
| Article | Year |
|---|---|
Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.
Topics: Adolescent; Adult; Age of Onset; Algorithms; Anticoagulants; Calreticulin; Child; Disease Management; Female; Germ-Line Mutation; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Male; Myelodysplastic-Myeloproliferative Diseases; Platelet Count; Quinazolines; Receptors, Thrombopoietin; Severity of Illness Index; Thrombocythemia, Essential; Thrombocytosis; Thrombophilia | 2021 |
Long-term management of thrombocytosis in essential thrombocythaemia.
Topics: Algorithms; Antineoplastic Agents; Aspirin; Female; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Pregnancy; PubMed; Quinazolines; Randomized Controlled Trials as Topic; Thrombocythemia, Essential; Thrombocytosis | 2009 |
Anagrelide: 20 years later.
Topics: Humans; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 2009 |
Comparison of the pharmacological mechanisms involved in the platelet lowering actions of anagrelide and hydroxyurea: a review.
Topics: Blood Platelets; Humans; Hydroxyurea; Platelet Aggregation Inhibitors; Quinazolines; Risk Assessment; Thrombocytosis | 2002 |
Thrombocytosis.
Topics: Aspirin; Clone Cells; Diagnosis, Differential; Humans; Hydroxyurea; Interferon-alpha; Plasmapheresis; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 2004 |
Anagrelide: an update on its mechanisms of action and therapeutic potential.
Topics: Clinical Trials as Topic; Drug Costs; Fibrinolytic Agents; Humans; Quinazolines; Thrombocytosis | 2004 |
Primary and secondary thrombocytosis in childhood.
Topics: Adolescent; Bacterial Infections; Blood Platelets; Child; Child, Preschool; Humans; Hydroxyurea; Infant; Infant, Newborn; Liver; Megakaryocytes; Mutation; Nucleic Acid Synthesis Inhibitors; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis; Thrombopoiesis; Thrombopoietin; Virus Diseases | 2005 |
A critical review of anagrelide therapy in essential thrombocythemia and related disorders.
Topics: Clinical Trials as Topic; Humans; Hydroxyurea; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 2005 |
Anagrelide for control of thrombocytosis due to myeloproliferative disorders.
Topics: Animals; Fibrinolytic Agents; Humans; Myeloproliferative Disorders; Quinazolines; Thrombocytosis | 2005 |
[Clinical application of anagrelide as a selective inhibitor of megakaryocyte system].
Topics: Fibrinolytic Agents; Humans; Quinazolines; Thrombocytosis; Thrombopoiesis | 2005 |
Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Clinical Trials as Topic; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 1994 |
Primary thrombocythemia: a current perspective.
Topics: Aspirin; Diagnosis, Differential; Humans; Hydroxyurea; Interferon Type I; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Plateletpheresis; Quinazolines; Recombinant Proteins; Thrombocytosis | 1995 |
Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders.
Topics: Fibrinolytic Agents; Humans; Polycythemia; Quinazolines; Thrombocytosis | 1997 |
New drugs in essential thrombocythemia and polycythemia vera.
Topics: Antineoplastic Agents; Fibrinolytic Agents; Humans; Interferon alpha-2; Interferon-alpha; Polycythemia Vera; Quinazolines; Recombinant Proteins; Thrombocytosis | 1997 |
Role of anagrelide in the treatment of thrombocytosis.
Topics: Humans; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 1999 |
[Anagrelide--a new drug to reduce platelets in myeloproliferative diseases].
Topics: Humans; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 1999 |
Diagnosis and treatment of thrombocythemia in myeloproliferative disorders.
Topics: Enzyme Inhibitors; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Polycythemia Vera; Quinazolines; Thrombocytosis | 2001 |
Therapeutic options for essential thrombocythemia and polycythemia vera.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Busulfan; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Phosphorus Radioisotopes; Polycythemia Vera; Quinazolines; Risk Assessment; Thrombocytosis | 2002 |
Other secondary sequelae of treatments for myeloproliferative disorders.
Topics: Antineoplastic Agents; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Polycythemia; Quinazolines; Thrombocytosis | 2002 |
The clinical spectrum of thrombocytosis and thrombocythemia.
Topics: Blood Platelets; Cytokines; Hematopoiesis; Humans; Hydroxyurea; Interferon Type I; Megakaryocytes; Platelet Aggregation; Platelet Count; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 1991 |
14 trial(s) available for quinazolines and Thrombocythemia
| Article | Year |
|---|---|
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Chromatography, High Pressure Liquid; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Randomized Controlled Trials as Topic; Solubility; Therapeutic Equivalency; Thrombocytosis; Young Adult | 2009 |
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 2009 |
Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Fibroblast Growth Factor 2; Fibrosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet-Derived Growth Factor; Quinazolines; Reticulin; Thrombocytosis; Transforming Growth Factor beta | 2002 |
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Topics: Adult; Aged; Chronic Disease; Diarrhea; Dose-Response Relationship, Drug; Female; Headache; Heart Rate; Humans; Male; Middle Aged; Myeloproliferative Disorders; Nausea; Patient Compliance; Patient Dropouts; Platelet Aggregation Inhibitors; Prospective Studies; Quinazolines; Thrombocytosis | 2004 |
Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Count; Quinazolines; Thrombocytosis; Treatment Outcome | 2004 |
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
Topics: Adult; Aged; Anemia; Chronic Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Retrospective Studies; Thrombocytosis; Thromboembolism; Treatment Outcome | 2004 |
Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
Topics: Adult; Drug Resistance; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Quinazolines; Thrombocytosis | 2005 |
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].
Topics: Administration, Oral; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finland; Follow-Up Studies; Humans; Male; Myeloproliferative Disorders; Prospective Studies; Quinazolines; Risk Assessment; Thrombocytosis; Treatment Outcome | 2006 |
[Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features].
Topics: Enzyme-Linked Immunosorbent Assay; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Megakaryocytes; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinazolines; Retrospective Studies; Statistics, Nonparametric; Stem Cell Factor; Thrombocythemia, Essential; Thrombocytosis; Thrombopoiesis; Thrombopoietin | 2006 |
Progression of bone marrow fibrosis in patients with essential thrombocythemia and polycythemia vera during anagrelide treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Fibrinolytic Agents; Humans; Hyaluronic Acid; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Prospective Studies; Quinazolines; Reticulin; Thrombocythemia, Essential; Thrombocytosis | 2007 |
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
Topics: Adult; Antineoplastic Agents; Aspirin; Biopsy; Blood Cell Count; Drug Therapy, Combination; Hematology; Humans; Hydroxyurea; Megakaryocytes; Observer Variation; Pathology, Clinical; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocytosis | 2008 |
TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.
Topics: Adult; Aged; Humans; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Receptors, Interleukin-6; Thrombocytosis; Thrombopoietin; Treatment Outcome | 2008 |
Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia.
Topics: Adult; Aged; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis | 2000 |
Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group.
Topics: Aged; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis; Treatment Outcome | 1992 |
28 other study(ies) available for quinazolines and Thrombocythemia
| Article | Year |
|---|---|
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.
Topics: Cytoreduction Surgical Procedures; Humans; Polycythemia Vera; Quinazolines; Thrombocythemia, Essential; Thrombocytosis; Thrombosis | 2022 |
Successful replantation of 2 digits in a patient with thrombocytosis after splenectomy: A case report.
Topics: Adolescent; Amputation, Traumatic; Finger Injuries; Fingers; Humans; Hydroxyurea; Male; Platelet Count; Quinazolines; Replantation; Splenectomy; Splenic Rupture; Thrombocytosis | 2018 |
Erlotinib-induced thrombocytosis in patients with recurrence of pancreatic cancer after distal pancreatectomy.
Topics: Chemotherapy, Adjuvant; Deoxycytidine; Erlotinib Hydrochloride; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatectomy; Pancreatic Neoplasms; Platelet Count; Quinazolines; Splenectomy; Thrombocytosis | 2013 |
Successful management of acute bleeding in essential thrombocythemia using automated cell separator.
Topics: Administration, Oral; Adolescent; Automation; Blood Platelets; Body Weight; Cell Separation; Female; Hemorrhage; Humans; Hydroxyurea; Platelet Count; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 2014 |
Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide.
Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Aspirin; Female; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Male; Mutation, Missense; Philadelphia Chromosome; Platelet Count; Prospective Studies; Quinazolines; Registries; Risk Factors; Thrombocytosis; Thrombosis | 2016 |
The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy.
Topics: Adult; Aged; Blood Platelets; Chronic Disease; Drug Therapy, Combination; Drug Tolerance; Female; Hemoglobins; Humans; Hydroxyurea; Male; Middle Aged; Myeloproliferative Disorders; Quinazolines; Retrospective Studies; Thrombocytosis | 2008 |
Platelet-lowering therapy with anagrelide as an adjuvant therapy for treatment of primary pulmonary neoplasm-associated extreme thrombocytosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Femoral Vein; Humans; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis | 2012 |
[Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
Topics: Blood Platelets; Chronic Disease; Fibrinolytic Agents; Humans; Megakaryocytes; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Proliferating Cell Nuclear Antigen; Quinazolines; Reference Values; Retrospective Studies; Thrombocytosis; Thrombopoiesis | 2002 |
Severe hypersensitivity pneumonitis associated with anagrelide.
Topics: Adrenal Cortex Hormones; Alveolitis, Extrinsic Allergic; Antineoplastic Agents; Drug Interactions; Female; Humans; Hydroxyurea; Injections, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 2003 |
Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
Topics: Adult; Aged; Biopsy; Blood Platelets; Bone Marrow; Chronic Disease; Drug Evaluation; Humans; Immunohistochemistry; Middle Aged; Myeloproliferative Disorders; Platelet Count; Quinazolines; Retrospective Studies; Thrombocytosis | 2003 |
Thrombocytosis.
Topics: Humans; Hydroxyurea; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 2004 |
Successful outcome with anagrelide in pregnancy.
Topics: Adult; Blood Cell Count; Female; Humans; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Quinazolines; Splenomegaly; Thrombocytosis | 2005 |
New approaches to the treatment of thrombocytosis.
Topics: Humans; Hydroxyurea; Interferon-alpha; Myeloproliferative Disorders; Platelet Count; Quinazolines; Thrombocytosis | 2003 |
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
Topics: Humans; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 2006 |
[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase].
Topics: Antineoplastic Agents; Benzamides; Blast Crisis; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Thrombocytosis | 2006 |
Examination of platelet function in whole blood under dynamic flow conditions with the cone and plate(let) analyzer: effect of erythrocytosis and thrombocytosis.
Topics: Benzamides; Blood Flow Velocity; Blood Platelets; Hematocrit; Humans; Imatinib Mesylate; Piperazines; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Polycythemia; Pyrimidines; Quinazolines; Thrombocytosis; Time Factors | 2007 |
[Appearance of leg ulcers associated with intake of anagrelide].
Topics: Adult; Fibrinolytic Agents; Humans; Hydroxyurea; Leg Ulcer; Male; Quinazolines; Thrombocytosis | 2007 |
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].
Topics: Adult; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Quinazolines; Thrombocytosis | 2007 |
Anagrelide for essential thrombocythemia.
Topics: Adult; Child; Child, Preschool; Dose-Response Relationship, Drug; Edema; Fees, Pharmaceutical; Humans; Hypotension; Platelet Aggregation Inhibitors; Quinazolines; Tachycardia; Thrombocytosis | 1997 |
Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
Topics: Female; Humans; Leg Ulcer; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Paraneoplastic Syndromes; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 1998 |
Successful treatment of essential thrombocythemia with anagrelide in a child.
Topics: Child; Female; Humans; Platelet Aggregation Inhibitors; Quinazolines; Thrombocytosis | 1998 |
[Anagrelide in control of myeloproliferative thrombocythemia: long-term experiences in 6 patients].
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocythemia, Essential; Thrombocytosis; Treatment Outcome | 1998 |
[Essential thrombocythemia as a cause of headache in young woman].
Topics: Adult; Combined Modality Therapy; Female; Fibrinolytic Agents; Headache; Humans; Plateletpheresis; Quinazolines; Thrombocytosis | 2000 |
Thrombocytosis--report of a case.
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis | 2000 |
Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
Topics: Adult; Antisickling Agents; beta-Thalassemia; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Remission Induction; Thrombocytosis | 2002 |
Cost-effectiveness considerations in the treatment of essential thrombocythemia.
Topics: Antineoplastic Agents; Cost-Benefit Analysis; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Quinazolines; Thrombocytosis | 2002 |
Anagrelide: a new drug for treating thrombocytosis.
Topics: Adult; Aged; Female; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Polycythemia Vera; Quinazolines; Thrombocythemia, Essential; Thrombocytosis | 1988 |
Wither the platelet?
Topics: Humans; Platelet Count; Quinazolines; Thrombocytosis | 1988 |